Join
Live feed
·
INSIDERFilingvia Quantisnow
Galectin Therapeutics Inc. logo

Czirr James C acquired $12,000 worth of shares (2,000 units at $6.00) and gifted 23,200 shares, decreasing direct ownership by 3% to 741,416 units (SEC Form 5)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GALT (Galectin Therapeutics Inc.) and more on Quantisnow.